Ablynx Announces Nanobody Drug Discovery Collaboration, Licence Agreement With Novo Nordisk

By: via Benzinga
Ablynx (OTC: ABYLY) today announced that it has entered into a global exclusive collaboration and licensing agreement with Novo Nordisk ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.